PFE - PFE ファイザ― ()


   COVID-19 vaccine developers prepare joint safety pledge: Report  2020/09/05 00:03:09 Channel NewsAsia
Several COVID-19 vaccine developers, including Pfizer Inc, Johnson & Johnson and Moderna Inc, plan to issue a public pledge not to seek government approval until their vaccine candidates are proven to be safe and effective, the Wall Street Journal reported on Friday.
   Ex-FDA Commissioner On How Coronavirus Vaccine Approval Could Come In Stages  2020/09/04 19:19:09 Benzinga
The Trump administration is urging individual states to start working on a strategy to distribute a coronavirus vaccine by Nov. 1, but some experts are skeptical of the quick timeline, as it comes just weeks after interim study results. Early Vaccine Data Within Weeks: U.K.-based AstraZeneca plc (NYSE: AZN ) is expected to release data in mid-September that could confirm that its vaccine can prevent people from contracting the disease. Prior to a scheduled U.S. Food and Drug Administration meeting Oct. 22, similar readouts are expected from Moderna Inc (NASDAQ: MRNA ) and BioNTech's collaboration with Pfizer Inc. (NYSE: PFE ). These readouts will merely be interim results, and a final readout will likely be released sometime from the middle of November through the end of the year, Rasmus Bech Hansen, CEO of the drug trial … Full story available on
   This might be the first coronavirus vaccine that stops severe COVID-19 cases  2020/09/04 19:16:34 BGR
A new chapter in the race to develop a safe and effective coronavirus vaccine has been written. An experimental vaccine was able to prevent severe illness in hamsters that were exposed to the virus four weeks after receiving the vaccine candidate. Johnson & Johnson researchers say this might be the first study that proves a vaccine can prevent severe complications like pneumonia in animal subjects. Phase 3 of the Ad26.COV2.S human trials will start in September, with the company looking to include 60,000 volunteers in the study. At least seven coronavirus vaccine candidates have now reached Phase 3 trials, which gives us hope that at least one of these drugs will be effective and safe. Three of these vaccines are made in China, one in Russia, and the other three come from Europe and the US. Russia and China have already approved their drugs for emergency use, with the former drawing plenty of criticism for the lack of scientific data that would back up the decision to push for early approval.
   'Widespread Covid vaccinations not until mid-2021'  2020/09/04 10:38:32 Economic Times India
The World Health Organization does not expect widespread vaccinations against COVID-19 until the middle of next year, a spokeswoman said on Friday, stressing the importance of rigorous checks on their effectiveness and safety.None of the candidate vaccines in advanced clinical trials so far has demonstrated a "clear signal" of efficacy at the level of at least 50% sought by the WHO, spokeswoman Margaret Harris said.Russia granted regulatory approval to a COVID-19 vaccine in August after less than two months of human testing, prompting some Western experts to question its safety and efficacy.U.S. public health officials and Pfizer Inc said on Thursday a vaccine could be ready for distribution as soon as late October. That would be just ahead of the U.S. election on Nov. 3 in which the pandemic is likely to be a major factor among voters deciding whether President Donald Trump wins a second term."We are really not expecting to see widespread vaccination until the middle of next year," Harris told a U.N. briefing in Geneva."This phase 3 must take longer because we need to see how truly protective the vaccine is and we also need to see how safe it is," she added.
   Coronavirus Vaccine update: Pfizer’s Covid-19 vaccine is in ‘very advanced stage’, final results expected in October  2020/09/04 10:13:00 The Financial Express
Coronavirus Vaccine news, update: Coronavirus vaccine by Pfizer-BioNTech is in a "very advanced stage" and the US-based drug-making company would be able to ascertain by the end of October whether the coronavirus vaccine they are developing is safe and effective, said Pharmaceutical giant Pfizer's chief executive, Dr. Albert Bourla. If the safety and the efficacy […]
   La farmacéutica Pfizer llega a un acuerdo para producir el remdesivir, el fármaco efectivo contra la Covid  2020/08/07 18:09:46 20minutos Spain
   Pfizer to Manufacture Gilead's Remdesivir for Covid-19 Treatment -- Update | MarketScreener  2020/08/07 17:33:01 MarketScreener
By Matt Grossman Gilead Sciences Inc. is expanding its manufacturing network to ramp up production of Covid-19 treatment remdesivir, and says it will be able to meet global demand in real time… | August 7, 2020
   Pfizer to Produce Gilead Virus-Treatment Candidate Remdesivir  2020/08/07 16:02:00 Yahoo Finance
Pfizer signed a multi-year agreement to produce Gilead Sciences' coronavirus-treatment candidate remdesivir.
   Pfizer llega a un acuerdo con Gilead para fabricar un fármaco contra el coronavirus  2020/08/07 15:52:49 Clarin
Se trata del remdesivir, el único medicamento autorizado para tratar el COVID-19 en Estados Unidos.
   Pfizer llega a un acuerdo con Gilead para fabricar un fármaco contra el Covid  2020/08/07 15:45:24 Cinco Dias El Pais
Servirá para escalar el suministro del remdesivir, que se ha probado efectivo en la reducción de las probabilidades de muerte por el virus